Insiders Updates
Moderna Inc (MRNA) receives a Neutral rating from Citigroup
Moderna Inc’s recent filing unveils that its Director Hussain Abbas unloaded Company’s shares for reported $8736.0 on Jun 11 ’25.
Menu
Moderna Inc’s recent filing unveils that its Director Hussain Abbas unloaded Company’s shares for reported $8736.0 on Jun 11 ’25.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Moderna Inc
Moderna Inc’s recent filing unveils that its Director Hussain Abbas unloaded Company’s shares for reported $8736.0 on Jun 11 ’25.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Moderna Inc
In a filing, Moderna Inc revealed its Director Hussain Abbas unloaded Company’s shares for reported $8736.0 on Jun 11 ’25.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Moderna Inc
The latest test results for COVID-19, a vaccine manufactured by biotech company Moderna Inc. (MRNA), were announced late last year. The
Tesla, Inc. (TSLA) increased to $816.04, up +7.94 percent. Morgan Stanley, which lifted its price target to $810 on Wall
Once again, pharmaceutical companies related to Covid-19 vaccines have been quite closely related. Novavax Inc. (NVAX) leapt by +2.93% to
Pfizer Inc (PFE) was down -0.45 percent to $37.27 whereas it’s German partner BioNTech SE (BNTX) fell by 3.10 percent